Cargando…
COVID-19 Immunization Rates in Patients with Inflammatory Bowel Disease Worldwide: A Systematic Review and Meta-Analysis
Individuals with Inflammatory Bowel Disease (IBD) are characterized by an increased vulnerability to complications stemming from infectious diseases. While these patients do not inherently face a heightened risk of SARS-CoV-2 infection compared to the general population, their vulnerability to sever...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611173/ https://www.ncbi.nlm.nih.gov/pubmed/37896927 http://dx.doi.org/10.3390/vaccines11101523 |
_version_ | 1785128429351337984 |
---|---|
author | Bianchi, Francesco Paolo Donghia, Rossella Tatoli, Rossella Bonfiglio, Caterina |
author_facet | Bianchi, Francesco Paolo Donghia, Rossella Tatoli, Rossella Bonfiglio, Caterina |
author_sort | Bianchi, Francesco Paolo |
collection | PubMed |
description | Individuals with Inflammatory Bowel Disease (IBD) are characterized by an increased vulnerability to complications stemming from infectious diseases. While these patients do not inherently face a heightened risk of SARS-CoV-2 infection compared to the general population, their vulnerability to severe COVID-19 complications and subsequent hospitalization is notably increased. The objective of our study is to quantitatively assess the global coverage of COVID-19 vaccination among individuals with IBD, achieved through a comprehensive meta-analysis and systematic review. Thirteen studies were systematically selected from scientific articles available in the MEDLINE/PubMed, ISI Web of Knowledge, and Scopus databases, spanning from 1 January 2021 to 25 July 2023. The pooled prevalence of COVID-19 vaccine uptake was estimated at 72% (95%CI = 59–83%) for at least one dose, 81% (95%CI = 68–91%) for the complete vaccination regimen, and 71% (95%CI = 46–91%) for the third dose. Analysis of the determinants influencing vaccination uptake revealed several significant associations. These encompassed Caucasian ethnicity, female sex, absence of immunosuppressive therapy, advanced age, prior receipt of the anti-influenza vaccine, absence of a history of COVID-19 infection, and the provision of advice from gastroenterologists, all linked to improved compliance. Our study underscores a noteworthy yet not entirely optimal COVID-19 vaccination coverage among individuals with IBD. A multifaceted approach is warranted to enhance vaccination rates. Within this context, the role of gastroenterologists extends beyond direct patient care, encompassing a pivotal responsibility in preventing complications stemming from post-infectious diseases. |
format | Online Article Text |
id | pubmed-10611173 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106111732023-10-28 COVID-19 Immunization Rates in Patients with Inflammatory Bowel Disease Worldwide: A Systematic Review and Meta-Analysis Bianchi, Francesco Paolo Donghia, Rossella Tatoli, Rossella Bonfiglio, Caterina Vaccines (Basel) Systematic Review Individuals with Inflammatory Bowel Disease (IBD) are characterized by an increased vulnerability to complications stemming from infectious diseases. While these patients do not inherently face a heightened risk of SARS-CoV-2 infection compared to the general population, their vulnerability to severe COVID-19 complications and subsequent hospitalization is notably increased. The objective of our study is to quantitatively assess the global coverage of COVID-19 vaccination among individuals with IBD, achieved through a comprehensive meta-analysis and systematic review. Thirteen studies were systematically selected from scientific articles available in the MEDLINE/PubMed, ISI Web of Knowledge, and Scopus databases, spanning from 1 January 2021 to 25 July 2023. The pooled prevalence of COVID-19 vaccine uptake was estimated at 72% (95%CI = 59–83%) for at least one dose, 81% (95%CI = 68–91%) for the complete vaccination regimen, and 71% (95%CI = 46–91%) for the third dose. Analysis of the determinants influencing vaccination uptake revealed several significant associations. These encompassed Caucasian ethnicity, female sex, absence of immunosuppressive therapy, advanced age, prior receipt of the anti-influenza vaccine, absence of a history of COVID-19 infection, and the provision of advice from gastroenterologists, all linked to improved compliance. Our study underscores a noteworthy yet not entirely optimal COVID-19 vaccination coverage among individuals with IBD. A multifaceted approach is warranted to enhance vaccination rates. Within this context, the role of gastroenterologists extends beyond direct patient care, encompassing a pivotal responsibility in preventing complications stemming from post-infectious diseases. MDPI 2023-09-25 /pmc/articles/PMC10611173/ /pubmed/37896927 http://dx.doi.org/10.3390/vaccines11101523 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Bianchi, Francesco Paolo Donghia, Rossella Tatoli, Rossella Bonfiglio, Caterina COVID-19 Immunization Rates in Patients with Inflammatory Bowel Disease Worldwide: A Systematic Review and Meta-Analysis |
title | COVID-19 Immunization Rates in Patients with Inflammatory Bowel Disease Worldwide: A Systematic Review and Meta-Analysis |
title_full | COVID-19 Immunization Rates in Patients with Inflammatory Bowel Disease Worldwide: A Systematic Review and Meta-Analysis |
title_fullStr | COVID-19 Immunization Rates in Patients with Inflammatory Bowel Disease Worldwide: A Systematic Review and Meta-Analysis |
title_full_unstemmed | COVID-19 Immunization Rates in Patients with Inflammatory Bowel Disease Worldwide: A Systematic Review and Meta-Analysis |
title_short | COVID-19 Immunization Rates in Patients with Inflammatory Bowel Disease Worldwide: A Systematic Review and Meta-Analysis |
title_sort | covid-19 immunization rates in patients with inflammatory bowel disease worldwide: a systematic review and meta-analysis |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611173/ https://www.ncbi.nlm.nih.gov/pubmed/37896927 http://dx.doi.org/10.3390/vaccines11101523 |
work_keys_str_mv | AT bianchifrancescopaolo covid19immunizationratesinpatientswithinflammatoryboweldiseaseworldwideasystematicreviewandmetaanalysis AT donghiarossella covid19immunizationratesinpatientswithinflammatoryboweldiseaseworldwideasystematicreviewandmetaanalysis AT tatolirossella covid19immunizationratesinpatientswithinflammatoryboweldiseaseworldwideasystematicreviewandmetaanalysis AT bonfigliocaterina covid19immunizationratesinpatientswithinflammatoryboweldiseaseworldwideasystematicreviewandmetaanalysis |